AI assistant
Sending…
HARROW, INC. — Director's Dealing 2008
Oct 1, 2008
31774_dirs_2008-09-30_f6a77c6b-b18f-4ad2-ac50-42834272e8b3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2008-09-26
Reporting Person: Singh Juliet (Director, CEO, Director and President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-09-26 | Common stock | P | 500 | $1.40 | Acquired | 1953625 | Direct |
| 2008-09-29 | Common stock | P | 500 | $1.40 | Acquired | 1954125 | Direct |
More from HARROW, INC.
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 8